Praxis Precision Medicines
PRAX
PRAX
111 hedge funds and large institutions have $971M invested in Praxis Precision Medicines in 2024 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
85% more funds holding
Funds holding: 60 → 111 (+51)
76% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 17
26.5% more ownership
Funds ownership: 93.73% → 120.24% (+27%)
Holders
111
Holding in Top 10
9
Calls
$2.95M
Puts
$1.36M
Top Buyers
| 1 | +$50.5M | |
| 2 | +$50.1M | |
| 3 | +$41.3M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$39.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$32.7M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$10.9M | |
| 3 | -$9.62M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$9.27M |
| 5 |
TLP
Tri Locum Partners
New York
|
-$8.68M |